Photoselective vaporization of the prostate for treating benign prostatic hyperplasia

References

• Kuntzman RS, Malek RS, Barrett DM et al. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology48, 575–583 (1996).
   PubMed Web of Science ®Google Scholar
• Heinrich E, Wendt-Nordahl G, Honeck P et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex vivo model. J. Endourol.24, 75–79 (2010).
   PubMedGoogle Scholar
• Reich O, Bachmann A, Siebels M et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J. Urol.173, 158–160 (2005).
   PubMed Web of Science ®Google Scholar
• Lee R, Saini R, Zoltan E et al. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J. Urol.180, 1551–1553 (2008).
   Google Scholar
• Kang HW, Jebens D, Malek RS et al. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J. Urol.180, 2675–2680 (2008).
   PubMed Web of Science ®Google Scholar
• Malek RS, Kang HW, Peng YS et al. Photoselective vaporization prostatectomy: experience with a novel 180 W 532 nm lithium triborate laser and fiber delivery system in living dogs. J. Urol.185, 712–718 (2011).
   Google Scholar
• Sandhu JS, Ng CK, Gonzalez RR et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J. Endourol.19, 1196–1198 (2005).
   PubMed Web of Science ®Google Scholar
• Woo H, Reich O, Bachmann A et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (I 80 ml). Eur. Urol. Suppl.7, 378–383 (2008).
   Google Scholar
• Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology51, 254–256 (1998).
   PubMed Web of Science ®Google Scholar
• Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J. Urol.163, 1730–1733 (2000).
   Google Scholar
• Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J. Endourol.17, 93–96 (2003).
   PubMed Web of Science ®Google Scholar
• Te AE, Malloy TR, Stein BS et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J. Urol.172, 1404 (2004).
   PubMed Web of Science ®Google Scholar
• Bouchier-Hayes DM, Anderson P, Van Appledorn S et al. KTP laser versus transurethral resection: early results of a randomized trial. J. Endourol.20, 580–585 (2006).
   PubMed Web of Science ®Google Scholar
• Horasanli K, Silay MS, Altay B et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 ml: a short-term prospective randomized trial. Urology71, 247–251 (2008).
   PubMed Web of Science ®Google Scholar
• Ruszat R, Seitz M, Wyler SF et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur. Urol.54, 893–901 (2008).
   PubMed Web of Science ®Google Scholar
• Ruszat R, Wyler S, Forster, T et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur. Urol.51, 1031–1041 (2007).
   PubMed Web of Science ®Google Scholar
• Spaliviero M, Araki M, Culkin DJ et al. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J. Endourol.23, 495–502 (2009).
   PubMedGoogle Scholar
• Rieken M, Ebinger Mundorff N, Bonkat G et al. Complications of laser prostatectomy: a review of recent data. World J. Urol.28, 53–62 (2010).
   Google Scholar
• Ahyai SA, Gilling P, Kaplan SA et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur. Urol.58, 384–397 (2010).
   PubMed Web of Science ®Google Scholar
• Naspro R, Bachmann A, Gilling P et al. A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur. Urol.55, 1345–1357 (2009).
   PubMed Web of Science ®Google Scholar
• Narayan P, Tewari A, Fournier G et al. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia. Urology45, 776–782 (1995).
   Google Scholar
• Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J. Urol.176, 1500–1506 (2006).
   PubMedGoogle Scholar
• Hermanns T, Sulser T, Fatzer M et al. Laser fibre deterioration and loss of power output during photo-selective 80-W potassium-titanyl-phosphate laser vaporisation of the prostate. Eur. Urol.55, 679–685 (2009).
   Google Scholar
• Seki N, Nomura H, Yamaguchi A et al. Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases. J. Endourol.22, 1731–1735 (2008).
   Google Scholar